drugset / Trial / NCT05272865
Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
RandomizedParallel-groupOpen-labelOther
Summary
Study based on the pharmacokinetic, pharmacodynamic, safety and stability evaluation of 3 standardized formulations of THC, to be used in healthy volunteers and post-chemotherapy patients as an adjuvant in the symptomatic treatment of the latter in discomfort associated with cancer treatment, with the aim of possible new therapeutic entities.
Timeline
- Start
- 2023-08-15
- Primary completion
- 2024-02-15
- Completion
- 2024-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CBC | Unknown | 5 mg/ml | Oral |
| Subject | CBG | Unknown | 5 mg/ml | Oral |
| Subject | Dronabinol | Other / unclassified | 5 mg/ml | Oral |
| Subject | Δ9-THC | Unknown | 5 mg/ml | Oral |